Detalhe da pesquisa
1.
ANETT: PhAse II trial of NEoadjuvant TAK-228 plus Tamoxifen in patients with hormone receptor-positive breast cancer.
Breast Cancer Res Treat
; 188(2): 433-439, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-33860388
2.
Progression-free Survival With First-line Endocrine-based Therapies Among Postmenopausal Women With HR+/HER2- Metastatic Breast Cancer:: A Network Meta-analysis.
Clin Ther
; 40(4): 628-639.e3, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29609880
3.
Progression-free survival with endocrine-based therapies following progression on non-steroidal aromatase inhibitor among postmenopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative metastatic breast cancer: a network meta-analysis.
Curr Med Res Opin
; 34(9): 1645-1652, 2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-29781326
4.
Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast Cancer.
Clin Cancer Res
; 23(19): 5687-5695, 2017 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28679771